Therefore, pharmacological evaluation of HO-1-dependent strong cellular immunity may provide valuable insights into mitigating deadly viral infections, including SARS-CoV-2 mutant variants, and also for reducing their associated serious pathogenic consequences in a safe and effective manner. The gene discussed is HMOX1; the disease is viral infectious disease.